ABL1 and acute lymphoblastic leukemia: To dissect the molecular mechanism responsible for the effect of FMD + VC on cancer-free survival, we performed RNA-seq analyses on spleen tissue isolated from BCR-ABL B-ALL mice at the end of the treatment (Figure 3e).